SC 13G 1 e264737v2.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ----------------- SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934* PHARMION CORPORATION -------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, $.001 PAR VALUE -------------------------------------------------------------------------------- (Title of Class of Securities) 71715B409 -------------------------------------------------------------------------------- (CUSIP Number) NOVEMBER 6, 2003 -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [_] Rule 13d-(c) [X] Rule 13d-1(d) ---------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ________________________________________________________________________________ 1. NAME OF REPORTING PERSONS CELGENE CORPORATION I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) 22-2711928 ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [_] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE ________________________________________________________________________________ NUMBER OF 5. SOLE VOTING POWER 1,939,598 SHARES _________________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER NONE OWNED BY _________________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER 1,939,598 REPORTING _________________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER NONE WITH ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH 1,939,598 REPORTING PERSON ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.1% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON (SEE INSTRUCTION) CO ITEM 1(a). NAME OF ISSUER: Pharmion Corporation ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 2528 28th Street, Boulder, Colorado 80301 ITEM 2(a). NAME OF PERSON FILING: Celgene Corporation ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR IF NONE, RESIDENCE: 7 Powder Horn Drive, Warren, New Jersey 07059 ITEM 2(c). CITIZENSHIP: Delaware ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, $.001 par value ITEM 2(e). CUSIP NUMBER: 71715B409 ITEM 3. Not applicable ITEM 4(a). OWNERSHIP. AMOUNT BENEFICIALLY OWNED: See Item 9 of the cover page attached hereto, which information is hereby incorporated by reference. ITEM 4(b). OWNERSHIP. PERCENT OF CLASS: See Item 11 of the cover page attached hereto, which information is hereby incorporated by reference. ITEM 4(c). OWNERSHIP. NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS: See Items 5 through 8 of the cover page attached hereto, which information is hereby incorporated by reference. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Not Applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not Applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not Applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not Applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP: Not Applicable. ITEM 10. CERTIFICATIONS. Not Applicable. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: March 8, 2004 CELGENE CORPORATION By: /s/Robert J.Hugin ---------------------------------------- Name: Robert J.Hugin Title: Chief Financial Officer